S-Nitrosylation of GPCR Regulatory Machinery as a Mechanism to Bias Signaling
Handbook of Experimental Pharmacology · 2025
DOI: 10.1007/164_2025_765 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Handbook of Experimental Pharmacology, 2025. Verfasst von Mingda Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Transformative Molecular Medicine and Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Signal Transduction, Receptors, G-Protein-Coupled, Protein Processing, Post-Translational, Nitric Oxide. Die Arbeit nennt 113 Literaturangaben. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Upon stimulation by endogenous ligands, G protein-coupled receptors (GPCRs) activate downstream signaling pathways through multiple mechanisms, including G protein subtypes, β-arrestins, and receptor-specific partners. Synthetic ligands may activate only a subset of these pathways, resulting in functional selectivity or signaling bias. Since not all signaling outputs are therapeutically desirable, there is pharmaceutical interest in exploiting biased signaling. Although much effort is focused on designing ligands to induce receptor conformations that result in signal bias, it is also true that cellular systems adapt dynamically in ways that tune receptor signaling, termed system bias. In this chapter, we provide evidence that posttranslational modification of receptor machinery by S-nitrosylation is an important regulator of system bias in GPCR signaling. S-nitrosylation has been reported to affect the function of multiple classes of GPCR signaling pathway components, including receptors, G proteins, G protein-coupled receptor kinases, β-arrestins, and others. Further, untargeted proteomic studies of S-nitrosylated proteins have identified over 60 GPCRs, most heterotrimeric G proteins, and numerous GPCR signaling components, hinting at a class effect and unifying mechanism to bias the functional repertoires of GPCRs in vivo. Thus, protein S-nitrosylation provides prototypic examples for how post-translational regulatory mechanisms bias GPCRs endogenously.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Transformative Molecular Medicine and Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
- Harrington Discovery Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
- Institute for Transformative Molecular Medicine and Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA. jss156@case.edu.
- Harrington Discovery Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. jss156@case.edu.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Chen, M., Grimmett, Z. W., Premont, R. T., & Stamler, J. S. (2025). S-Nitrosylation of GPCR Regulatory Machinery as a Mechanism to Bias Signaling. Handbook of Experimental Pharmacology. https://doi.org/10.1007/164_2025_765
Vancouver
Chen M, Grimmett ZW, Premont RT, Stamler JS. S-Nitrosylation of GPCR Regulatory Machinery as a Mechanism to Bias Signaling. Handbook of Experimental Pharmacology. 2025. doi:10.1007/164_2025_765
BibTeX
@article{Chen2025,
author = {Chen, Mingda and Grimmett, Zachary W and Premont, Richard T and Stamler, Jonathan S},
title = {S-Nitrosylation of GPCR Regulatory Machinery as a Mechanism to Bias Signaling},
journal = {Handbook of Experimental Pharmacology},
year = {2025},
doi = {10.1007/164_2025_765}
}
EUVIMED